Clinical Trial Update: S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a multi-agent chemotherapy regimen with rituximab and Y-90 ibritumomab tiuxetan followed by radiotherapy in early-stage non-Hodgkin's l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Radiation therapy
• Rituximab (rituximab)
• Vincristine (vincristine)
• Yttrium-90 ibritumomab tiuxetan (yttrium-90 ibritumomab tiuxetan)
• ibritumomab tiuxetan (ibritumomab tiuxetan)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-04-03